Dendritic cell-based vaccination for renal cell carcinoma: challenges in clinical trials.
about
Dendritic-cell-based technology landscape: Insights from patents and citation networksPersonalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignanciesExploiting natural anti-tumor immunity for metastatic renal cell carcinoma.Brain Tumor Immunotherapy: What have We Learned so Far?MCPIP1 contributes to clear cell renal cell carcinomas development.Exosomes derived from rAAV/AFP-transfected dendritic cells elicit specific T cell-mediated immune responses against hepatocellular carcinoma
P2860
Dendritic cell-based vaccination for renal cell carcinoma: challenges in clinical trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Dendritic cell-based vaccination for renal cell carcinoma: challenges in clinical trials.
@en
type
label
Dendritic cell-based vaccination for renal cell carcinoma: challenges in clinical trials.
@en
prefLabel
Dendritic cell-based vaccination for renal cell carcinoma: challenges in clinical trials.
@en
P2093
P2860
P356
P1433
P1476
Dendritic cell-based vaccination for renal cell carcinoma: challenges in clinical trials.
@en
P2093
Jianming Tan
Lianming Liao
P2860
P304
P356
10.2217/IMT.12.107
P577
2012-10-01T00:00:00Z